Scarica l'app Stockscreener
1.43
5.93%
0.08
Dopo l'orario di chiusura:
1.40
-0.03
-2.10%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GERN Giù?
Forum
Previsione
Geron Corp Borsa (GERN) Ultime notizie
Geron Corporation Surges: CEO Appointment and Q2 Triumph - StocksToTrade
Geron Corporation Breaks Below Key Support LevelQuarterly Portfolio Report & Fast Exit/Entry Strategy Plans - 선데이타임즈
Geron Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Leerink Partnrs Issues Positive Estimate for Geron Earnings - Defense World
Visual trend scoring systems applied to Geron CorporationChart-Based Entry Confirmation for Beginners - Newser
Q1 Earnings Forecast for Geron Issued By Wedbush - Defense World
Geron Corporation (NASDAQ:GERN) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron: I Think We've Seen This Movie Before (NASDAQ:GERN) - Seeking Alpha
A Quick Look at Today's Ratings for Geron(GERN.US), With a Forecast Between $4 to $5 - 富途牛牛
Geron Corporation (NASDAQ:GERN) Q2 2025 Earnings Call Transcript - Insider Monkey
Geron: Q2 Earnings Snapshot - Huron Daily Tribune
Geron Corp (GERN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - Investing.com Canada
Geron (GERN) Q2 Revenue Jumps 5,477% - sharewise.com
Semerjian to lead Geron - BioCentury
Geron reports Q2 EPS (2c), consensus (3c) - TipRanks
Geron Corporation Set to Release Q2 Financial Results, Eyes Market Reaction - StocksToTrade
Earnings call transcript: Geron surpasses Q2 2025 forecasts, stock rises By Investing.com - Investing.com South Africa
Earnings call transcript: Geron surpasses Q2 2025 forecasts, stock rises - Investing.com
Geron appoints Harout Semerjian as CEO - TipRanks
Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Geron Q2 2025 presentation: RYTELO sales climb 24%, stock jumps premarket - Investing.com
Geron earnings beat, revenue topped estimates By Investing.com - Investing.com Canada
Geron earnings beat, revenue topped estimates - Investing.com
Geron appoints Harout Semerjian as new CEO amid RYTELO expansion - Investing.com
Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights - Yahoo Finance
Geron Taps Former Novartis Hematology Leader as CEO: 30-Year Expert to Scale RYTELO Commercial Launch - Stock Titan
Universal Beteiligungs und Servicegesellschaft mbH Purchases New Holdings in Geron Corporation (NASDAQ:GERN) - Defense World
What is the dividend policy of Geron Corporation stockUnlock daily trading alerts for profits - Jammu Links News
What makes Geron Corporation stock price move sharplyExtraordinary earning power - Jammu Links News
Ball Corp Set to Report Q2 Earnings: What Lies Ahead for the Stock? - The Globe and Mail
Leerink Partners Reiterates a Buy Rating on Geron Corporation (GERN) With a $3 PT - Insider Monkey
Commercial Stage Biotech Geron Sets Q2 Earnings Release: Key Financial Updates Coming August 6 - Stock Titan
Geron Plans to Announce Second Quarter 2025 Financial Results on August 6, 2025 - Business Wire
How high can Geron Corporation stock price go in 2025Real Time Stock Signal - metal.it
What is the risk reward ratio of investing in Geron Corporation stockGet timely market insights for better trades - Jammu Links News
How volatile is Geron Corporation stock compared to the marketDynamic growth stocks - Jammu Links News
Geron (GERN.O) Surges 5.08%: What’s Driving the Intraday Rally? - AInvest
What analysts say about Geron Corporation stockOutstanding stock performance - jammulinksnews.com
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 18, 2025 - BioSpace
Market Sentiment Around Loss-Making Geron Corporation (NASDAQ:GERN) - simplywall.st
Geron Corporation Stock Analysis and ForecastOutstanding capital returns - jammulinksnews.com
Geron Corporation (GERN) Plunges 3.88% to 2025 Low on Earnings Miss - AInvest
Commercial Stage Biotech Geron Expands Team with 342,000 Share Equity Package for Strategic New Hires - Stock Titan
Why Geron Corporation stock attracts strong analyst attentionTechnical Breakout List - Newser
Geron Presents Positive RYTELO Data for LR-MDS at ASCO & EHA, Highlights Efficacy, Myelofibrosis Program Progress - Insider Monkey
Geron Corporation (NASDAQ:GERN) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Geron (NASDAQ:GERN) Shares Gap Down – Here’s Why - Defense World
Cambridge Investment Research Advisors Inc. Cuts Stock Position in Geron Corporation (NASDAQ:GERN) - Defense World
Here’s Why Geron Corp. (NASDAQ:GERN) Crashed Today - MSN
Geron resumed with a Sell at Goldman Sachs - TipRanks
Geron Corp’s Rytelo Faces Market Challenges and Declining Physician Adoption, Supporting Sell Rating - TipRanks
Goldman Sachs resumes Geron stock coverage with Sell rating on weak Rytelo sales - Investing.com
Geron Corp (GERN) Stock: A Year of Highs and Lows - investchronicle.com
Leerink Partners Reiterates a Buy Rating on Geron Corporation (GERN) - MSN
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):